Similar articles

• A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients.

  Hanto DW, Jendrisak MD, McCullough CS, So SK, Marsh JW, Rush T, Michalski S, Phelan D, Mohanakumar T. Hanto DW, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1050-1. Transplant Proc. 1991. PMID: 1899150 Clinical Trial. No abstract available.
• MALG vs OKT3 following renal transplantation: a randomized prospective trial.

  Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DE, Najarian JS. Frey DJ, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1048-9. Transplant Proc. 1991. PMID: 1899149 Clinical Trial. No abstract available.
• Sequential immunosuppression: three years' experience in 240 cadaveric renal transplants.

  Light JA, Jonsson J, Khawand N, Ali A, Aquino A, Currier CB, Romolo J, Gonzalez J, Korb S. Light JA, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1032-5. Transplant Proc. 1991. PMID: 1899145 No abstract available.
• Nursing implications of immunosuppression in transplantation.

  Shaefer M, Williams L. Shaefer M, et al. Nurs Clin North Am. 1991 Jun;26(2):291-314. Nurs Clin North Am. 1991. PMID: 1904575 Review.
• Mechanism, pathophysiology, diagnosis, and management of renal transplant rejection.

  Rao KV. Rao KV. Med Clin North Am. 1990 Jul;74(4):1039-57. doi: 10.1016/s0025-7125(16)30535-1. Med Clin North Am. 1990. PMID: 2114510 Review.